Systematic review / meta-analysis / 2022
Taurine supplementation significantly reduced HbA1c, fasting blood sugar, and HOMA-IR in patients with diabetes.
A meta-analysis of 5 randomized controlled trials (N = 209 participants) evaluated the effects of taurine supplementation in patients with diabetes. Compared with controls, taurine significantly reduced HbA1c (SMD -0.41 [95% CI: -0.74, -0.09], p = 0.01), fasting blood sugar (SMD -1.28 [95% CI: -2.42, -0.14], p = 0.03), and HOMA-IR (SMD -0.64 [95% CI: -1.22, -0.06], p = 0.03). Reductions in insulin (SMD -0.48 [95% CI: -0.99, 0.03], p = 0.06) and triglycerides (SMD -0.26 [95% CI: -0.55, 0.02], p = 0.07) did not reach statistical significance, and no significant effects were found for serum lipids, blood pressure, or body composition.
- Study type
- Systematic review and meta-analysis of randomized controlled trials
- Who was studied
- 209 patients with diabetes across 5 randomized controlled trials
- What was measured
- Glycemic indices (HbA1c, fasting blood sugar, HOMA-IR, insulin), serum lipids, blood pressure, and body composition
THE PAPER
The effects of taurine supplementation on diabetes mellitus in humans: A systematic review and meta-analysis.
Tao X, Zhang Z, Yang Z, Rao B. Food Chem (Oxf), 2022.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.